Shin Nippon Biomedical Laboratories, Ltd.'s market cap is currently ¥65.45B. The company's EPS TTM is ¥118.71; its P/E ratio is 13.24; and it has a dividend yield of 3.18%. Shin Nippon Biomedical Laboratories, Ltd. is scheduled to report earnings on February 5, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
Income Statement
Total Revenue	¥ 26.45B	¥ 25.09B	¥ 17.75B	¥ 15.11B	¥ 14.56B
Gross Profit	¥ 14.28B	¥ 13.05B	¥ 9.69B	¥ 7.55B	¥ 7.62B
Operating Income	¥ 4.16B	¥ 5.25B	¥ 4.20B	¥ 2.53B	¥ 2.23B
EBITDA	¥ 8.98B	¥ 9.49B	¥ 9.49B	¥ 5.55B	¥ 4.53B
Net Income	¥ 5.53B	¥ 6.06B	¥ 7.13B	¥ 3.66B	¥ 2.55B
Balance Sheet
Cash & Short-Term Investments	¥ 10.61B	¥ 10.53B	¥ 7.00B	¥ 7.29B	¥ 5.25B
Total Assets	¥ 76.30B	¥ 57.24B	¥ 39.31B	¥ 36.97B	¥ 39.00B
Total Debt	¥ 26.19B	¥ 18.76B	¥ 9.14B	¥ 12.69B	¥ 14.92B
Net Debt	¥ 15.91B	¥ 8.23B	¥ 2.51B	¥ 5.46B	¥ 9.67B
Total Liabilities	¥ 42.14B	¥ 30.88B	¥ 19.59B	¥ 21.13B	¥ 22.62B
Stockholders' Equity	¥ 34.11B	¥ 26.21B	¥ 19.56B	¥ 15.73B	¥ 16.29B
Cash Flow
Free Cash Flow	¥ -6.50B	¥ -951.70M	¥ 4.34B	¥ 3.63B	¥ 1.79B
Operating Cash Flow	¥ 2.11B	¥ 4.00B	¥ 5.95B	¥ 4.75B	¥ 3.02B
Investing Cash Flow	¥ -6.91B	¥ -5.93B	¥ -4.27B	¥ -268.66M	¥ -1.46B
Financing Cash Flow	¥ 5.32B	¥ 6.27B	¥ -4.91B	¥ -2.47B	¥ -1.45B

Currency in JPY

Shin Nippon Biomedical Laboratories, Ltd. Earnings and Revenue History

Income Statement >

Shin Nippon Biomedical Laboratories, Ltd. Debt to Assets

Balance Sheet >

Shin Nippon Biomedical Laboratories, Ltd. Cash Flow

Cash Flow >

Shin Nippon Biomedical Laboratories, Ltd. Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing